awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46980729-09BE2B54-BF4B-4CF3-9184-85F43D521ABC
Q46980729-09BE2B54-BF4B-4CF3-9184-85F43D521ABC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46980729-09BE2B54-BF4B-4CF3-9184-85F43D521ABC
Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
P2860
Q46980729-09BE2B54-BF4B-4CF3-9184-85F43D521ABC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46980729-09BE2B54-BF4B-4CF3-9184-85F43D521ABC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c91e82955ab715cc67e0c01ae6b42c963aafbe6a
P2860
The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL).